Background Dysponea, muscle wasting, and fatigue are common manifestations in interstitial lung disease (ILD). Pulmonary rehabilitation programmes (PRP) aim to improve symptoms and quality of life in ILD but research is very limited about the role and feasibility of inspiratory muscle training (IMT) in PRP. Methods Six patients with a mixed disciplinary team diagnosis of ILD (5 males, median age 80 range 67-85) participated in a tailored PRP either in an IMT (n=3) or control group (n=3). PRP involved three days of exercises, one conducted in a hospice day therapy unit and two at home. The PRP session involved aerobic, strength, and stretching exercises with integrated education and relaxation sessions. Both groups received the same PRP, supplemented in the IMT group by the use of a POWERbreathe Medic plus respiratory muscle trainer. The trainer use consisted of 30 breaths twice daily with personalised resistance levels of 40% Maximal Inspiratory Pressure (MIP), which was measured and adjusted weekly. ILD outcome measures were recorded before and after PRP. Results All patients completed the PRP with adherence of 80% for the full program. There were no major complications or adverse events and patients reported liking and enjoying the PRP and environmental setting. Introduction and Objectives The incidence of idiopathic pulmonary fibrosis (IPF) has been increasing at a rate of 5% per annum since 2000. By definition, the diagnosis of IPF is not made in the presence of an identifiable cause. However, the distribution of the disease in the population (more common in men, manual workers, and those living in more industrial areas of the country) suggests a causal contribution from an occupational or environmental source. This would be expected to produce a cohort effect. Our aim was to examine trends in IPF mortality data for evidence of such an effect. Methods Age and sex stratified mortality data for IPF were obtained for England and Wales from the Office of National Statistics for the period 1974-2012. Data were ageAbstract P160 Figure 1 Poster sessions A170 Thorax 2017;72(Suppl 3):A1-278
